P3 Health Partners Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Significant Accounting Policies (Tables)

Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2022

Significant Accounting Policies

Summary of sources (by product type) from which the Company's revenues are derived


		Successor											Predecessor
		Year Ended					December 3, 2021						January 1, 2021
		December 31,					through December 31,						through December 2,
Revenue Type		2022			% of Total		2021			% of Total			2021			% of Total
Capitated revenue		$	1,034,800		99	%	$	57,224		97	%		$	567,735		98	%
Other patient service revenue:
Clinical fees & insurance revenue			6,158		0	%		751		2	%			4,318		1	%
Shared risk revenue			351		0	%		181		0	%			602		0	%
Care coordination / management fees			7,924		1	%		600		1	%			5,880		1	%
Incentive fees			238		0	%		6		0	%			67		0	%
Total other patient service revenue			14,671		1	%		1,538		3	%			10,867		2	%
Total revenue		$	1,049,471		100	%	$	58,762		100	%		$	578,602		100	%

Summary of estimated useful lives applicable to PP&E


Classification		Depreciation Cycle
Leasehold improvements (cycle: lease term)		1 to 10 Years
Furniture and fixtures		7 Years
Computer equipment		3 Years
Medical equipment		7 Years
Software		3 Years